Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07870499
NA

Effect of Prophylactic Tranexamic Acid on Perioperative Blood Loss in High-Risk Cesarean Delivery: A Randomized Controlled Study

Sponsor: Mert Yetgin

View on ClinicalTrials.gov

Summary

This randomized study evaluated whether prophylactic tranexamic acid (TXA) reduces perioperative blood loss in women at increased risk of postpartum hemorrhage undergoing elective cesarean delivery. Women aged 18-45 years with at least one risk factor for postpartum hemorrhage were included. The anesthesia technique, spinal or general anesthesia, was selected before randomization based on clinical considerations and patient preference. Within each anesthesia group, participants were randomized to receive either 1 g intravenous TXA after umbilical cord clamping or no TXA. The main outcome was estimated blood loss calculated from perioperative hematocrit values. Other outcomes included postpartum hemorrhage, blood transfusion, changes in hemoglobin and hematocrit, need for additional uterotonic medications, adverse events, and thromboembolic events during follow-up.

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

84

Start Date

2022-01-05

Completion Date

2023-02-05

Last Updated

2026-10-13

Healthy Volunteers

No

Interventions

DRUG

Tranexamic Acid

Participants assigned to the tranexamic acid groups received 1 g intravenous tranexamic acid administered slowly after umbilical cord clamping, concomitantly with the standardized oxytocin regimen.

Locations (1)

Pamukkale University Hospital

Denizli, Merkezefendi, Turkey (Türkiye)